Global Female Contraceptive Market Insights and Forecast to 2026

Publisher Name :
Date: 10-Jul-2020
No. of pages: 117
Inquire Before Buying

Female Contraceptive market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Contraceptive market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Female Contraceptive market is segmented into

- Female Contraceptive Devices

- Female Contraceptive Drugs

Segment by Application, the Female Contraceptive market is segmented into

- Online Stores

- Retail Outlets

Regional and Country-level Analysis

The Female Contraceptive market is analysed and market size information is provided by regions (countries).

The key regions covered in the Female Contraceptive market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Female Contraceptive Market Share Analysis

Female Contraceptive market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Female Contraceptive business, the date to enter into the Female Contraceptive market, Female Contraceptive product introduction, recent developments, etc.

The major vendors covered:

- Merck

- Pfizer

- Allergan

- Bayer

- Okamoto Industries

- Reckitt Benckiser

- Lupin Pharmaceuticals

- Foundation Consumer Healthcare

- Teva Pharmaceuticals

- Ansell

- Ferring Pharmaceuticals

- Fuji Latex

- Janssen Pharmaceuticals

Global Female Contraceptive Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Female Contraceptive Product Introduction
1.2 Market Segments
1.3 Key Female Contraceptive Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Female Contraceptive Market Size Growth Rate by Type
1.4.2 Female Contraceptive Devices
1.4.3 Female Contraceptive Drugs
1.5 Market by Application
1.5.1 Global Female Contraceptive Market Size Growth Rate by Application
1.5.2 Online Stores
1.5.3 Retail Outlets
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Female Contraceptive Market Size, Estimates and Forecasts
2.1.1 Global Female Contraceptive Revenue 2015-2026
2.1.2 Global Female Contraceptive Sales 2015-2026
2.2 Global Female Contraceptive, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Female Contraceptive Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Female Contraceptive Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Female Contraceptive Competitor Landscape by Players
3.1 Female Contraceptive Sales by Manufacturers
3.1.1 Female Contraceptive Sales by Manufacturers (2015-2020)
3.1.2 Female Contraceptive Sales Market Share by Manufacturers (2015-2020)
3.2 Female Contraceptive Revenue by Manufacturers
3.2.1 Female Contraceptive Revenue by Manufacturers (2015-2020)
3.2.2 Female Contraceptive Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Female Contraceptive Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Female Contraceptive Revenue in 2019
3.2.5 Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Female Contraceptive Price by Manufacturers
3.4 Female Contraceptive Manufacturing Base Distribution, Product Types
3.4.1 Female Contraceptive Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Female Contraceptive Product Type
3.4.3 Date of International Manufacturers Enter into Female Contraceptive Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Female Contraceptive Market Size by Type (2015-2020)
4.1.1 Global Female Contraceptive Sales by Type (2015-2020)
4.1.2 Global Female Contraceptive Revenue by Type (2015-2020)
4.1.3 Female Contraceptive Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Female Contraceptive Market Size Forecast by Type (2021-2026)
4.2.1 Global Female Contraceptive Sales Forecast by Type (2021-2026)
4.2.2 Global Female Contraceptive Revenue Forecast by Type (2021-2026)
4.2.3 Female Contraceptive Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Female Contraceptive Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Female Contraceptive Market Size by Application (2015-2020)
5.1.1 Global Female Contraceptive Sales by Application (2015-2020)
5.1.2 Global Female Contraceptive Revenue by Application (2015-2020)
5.1.3 Female Contraceptive Price by Application (2015-2020)
5.2 Female Contraceptive Market Size Forecast by Application (2021-2026)
5.2.1 Global Female Contraceptive Sales Forecast by Application (2021-2026)
5.2.2 Global Female Contraceptive Revenue Forecast by Application (2021-2026)
5.2.3 Global Female Contraceptive Price Forecast by Application (2021-2026)
6 North America
6.1 North America Female Contraceptive by Country
6.1.1 North America Female Contraceptive Sales by Country
6.1.2 North America Female Contraceptive Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Female Contraceptive Market Facts & Figures by Type
6.3 North America Female Contraceptive Market Facts & Figures by Application
7 Europe
7.1 Europe Female Contraceptive by Country
7.1.1 Europe Female Contraceptive Sales by Country
7.1.2 Europe Female Contraceptive Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Female Contraceptive Market Facts & Figures by Type
7.3 Europe Female Contraceptive Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Female Contraceptive by Region
8.1.1 Asia Pacific Female Contraceptive Sales by Region
8.1.2 Asia Pacific Female Contraceptive Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Female Contraceptive Market Facts & Figures by Type
8.3 Asia Pacific Female Contraceptive Market Facts & Figures by Application
9 Latin America
9.1 Latin America Female Contraceptive by Country
9.1.1 Latin America Female Contraceptive Sales by Country
9.1.2 Latin America Female Contraceptive Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Female Contraceptive Market Facts & Figures by Type
9.3 Central & South America Female Contraceptive Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Female Contraceptive by Country
10.1.1 Middle East and Africa Female Contraceptive Sales by Country
10.1.2 Middle East and Africa Female Contraceptive Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Female Contraceptive Market Facts & Figures by Type
10.3 Middle East and Africa Female Contraceptive Market Facts & Figures by Application
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Female Contraceptive Products Offered
11.1.5 Merck Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Female Contraceptive Products Offered
11.2.5 Pfizer Related Developments
11.3 Allergan
11.3.1 Allergan Corporation Information
11.3.2 Allergan Description and Business Overview
11.3.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Allergan Female Contraceptive Products Offered
11.3.5 Allergan Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Female Contraceptive Products Offered
11.4.5 Bayer Related Developments
11.5 Okamoto Industries
11.5.1 Okamoto Industries Corporation Information
11.5.2 Okamoto Industries Description and Business Overview
11.5.3 Okamoto Industries Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Okamoto Industries Female Contraceptive Products Offered
11.5.5 Okamoto Industries Related Developments
11.6 Reckitt Benckiser
11.6.1 Reckitt Benckiser Corporation Information
11.6.2 Reckitt Benckiser Description and Business Overview
11.6.3 Reckitt Benckiser Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Reckitt Benckiser Female Contraceptive Products Offered
11.6.5 Reckitt Benckiser Related Developments
11.7 Lupin Pharmaceuticals
11.7.1 Lupin Pharmaceuticals Corporation Information
11.7.2 Lupin Pharmaceuticals Description and Business Overview
11.7.3 Lupin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lupin Pharmaceuticals Female Contraceptive Products Offered
11.7.5 Lupin Pharmaceuticals Related Developments
11.8 Foundation Consumer Healthcare
11.8.1 Foundation Consumer Healthcare Corporation Information
11.8.2 Foundation Consumer Healthcare Description and Business Overview
11.8.3 Foundation Consumer Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Foundation Consumer Healthcare Female Contraceptive Products Offered
11.8.5 Foundation Consumer Healthcare Related Developments
11.9 Teva Pharmaceuticals
11.9.1 Teva Pharmaceuticals Corporation Information
11.9.2 Teva Pharmaceuticals Description and Business Overview
11.9.3 Teva Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Teva Pharmaceuticals Female Contraceptive Products Offered
11.9.5 Teva Pharmaceuticals Related Developments
11.10 Ansell
11.10.1 Ansell Corporation Information
11.10.2 Ansell Description and Business Overview
11.10.3 Ansell Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Ansell Female Contraceptive Products Offered
11.10.5 Ansell Related Developments
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Description and Business Overview
11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Merck Female Contraceptive Products Offered
11.1.5 Merck Related Developments
11.12 Fuji Latex
11.12.1 Fuji Latex Corporation Information
11.12.2 Fuji Latex Description and Business Overview
11.12.3 Fuji Latex Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Fuji Latex Products Offered
11.12.5 Fuji Latex Related Developments
11.13 Janssen Pharmaceuticals
11.13.1 Janssen Pharmaceuticals Corporation Information
11.13.2 Janssen Pharmaceuticals Description and Business Overview
11.13.3 Janssen Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Janssen Pharmaceuticals Products Offered
11.13.5 Janssen Pharmaceuticals Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Female Contraceptive Market Estimates and Projections by Region
12.1.1 Global Female Contraceptive Sales Forecast by Regions 2021-2026
12.1.2 Global Female Contraceptive Revenue Forecast by Regions 2021-2026
12.2 North America Female Contraceptive Market Size Forecast (2021-2026)
12.2.1 North America: Female Contraceptive Sales Forecast (2021-2026)
12.2.2 North America: Female Contraceptive Revenue Forecast (2021-2026)
12.2.3 North America: Female Contraceptive Market Size Forecast by Country (2021-2026)
12.3 Europe Female Contraceptive Market Size Forecast (2021-2026)
12.3.1 Europe: Female Contraceptive Sales Forecast (2021-2026)
12.3.2 Europe: Female Contraceptive Revenue Forecast (2021-2026)
12.3.3 Europe: Female Contraceptive Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Female Contraceptive Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Female Contraceptive Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Female Contraceptive Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Female Contraceptive Market Size Forecast by Region (2021-2026)
12.5 Latin America Female Contraceptive Market Size Forecast (2021-2026)
12.5.1 Latin America: Female Contraceptive Sales Forecast (2021-2026)
12.5.2 Latin America: Female Contraceptive Revenue Forecast (2021-2026)
12.5.3 Latin America: Female Contraceptive Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Female Contraceptive Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Female Contraceptive Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Female Contraceptive Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Female Contraceptive Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Female Contraceptive Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Female Contraceptive Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Female Contraceptive Market Segments
Table 2. Ranking of Global Top Female Contraceptive Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Female Contraceptive Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Female Contraceptive Devices
Table 5. Major Manufacturers of Female Contraceptive Drugs
Table 6. Global Female Contraceptive Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Female Contraceptive Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Female Contraceptive Sales by Regions 2015-2020 (K Units)
Table 9. Global Female Contraceptive Sales Market Share by Regions (2015-2020)
Table 10. Global Female Contraceptive Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Female Contraceptive Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Female Contraceptive Sales Share by Manufacturers (2015-2020)
Table 13. Global Female Contraceptive Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Female Contraceptive by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Contraceptive as of 2019)
Table 15. Female Contraceptive Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Female Contraceptive Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Female Contraceptive Price (2015-2020) (USD/Unit)
Table 18. Female Contraceptive Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Female Contraceptive Product Type
Table 20. Date of International Manufacturers Enter into Female Contraceptive Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 23. Global Female Contraceptive Sales Share by Type (2015-2020)
Table 24. Global Female Contraceptive Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Female Contraceptive Revenue Share by Type (2015-2020)
Table 26. Female Contraceptive Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 28. Global Female Contraceptive Sales Share by Application (2015-2020)
Table 29. North America Female Contraceptive Sales by Country (2015-2020) (K Units)
Table 30. North America Female Contraceptive Sales Market Share by Country (2015-2020)
Table 31. North America Female Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Female Contraceptive Revenue Market Share by Country (2015-2020)
Table 33. North America Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 34. North America Female Contraceptive Sales Market Share by Type (2015-2020)
Table 35. North America Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 36. North America Female Contraceptive Sales Market Share by Application (2015-2020)
Table 37. Europe Female Contraceptive Sales by Country (2015-2020) (K Units)
Table 38. Europe Female Contraceptive Sales Market Share by Country (2015-2020)
Table 39. Europe Female Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Female Contraceptive Revenue Market Share by Country (2015-2020)
Table 41. Europe Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 42. Europe Female Contraceptive Sales Market Share by Type (2015-2020)
Table 43. Europe Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 44. Europe Female Contraceptive Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Female Contraceptive Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Female Contraceptive Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Female Contraceptive Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Female Contraceptive Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Female Contraceptive Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Female Contraceptive Sales Market Share by Application (2015-2020)
Table 53. Latin America Female Contraceptive Sales by Country (2015-2020) (K Units)
Table 54. Latin America Female Contraceptive Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Female Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Female Contraceptive Revenue Market Share by Country (2015-2020)
Table 57. Latin America Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 58. Latin America Female Contraceptive Sales Market Share by Type (2015-2020)
Table 59. Latin America Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 60. Latin America Female Contraceptive Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Female Contraceptive Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Female Contraceptive Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Female Contraceptive Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Female Contraceptive Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Female Contraceptive Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Female Contraceptive Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Female Contraceptive Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Female Contraceptive Sales Market Share by Application (2015-2020)
Table 69. Merck Corporation Information
Table 70. Merck Description and Major Businesses
Table 71. Merck Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Merck Product
Table 73. Merck Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Allergan Corporation Information
Table 80. Allergan Description and Major Businesses
Table 81. Allergan Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Allergan Product
Table 83. Allergan Recent Development
Table 84. Bayer Corporation Information
Table 85. Bayer Description and Major Businesses
Table 86. Bayer Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Bayer Product
Table 88. Bayer Recent Development
Table 89. Okamoto Industries Corporation Information
Table 90. Okamoto Industries Description and Major Businesses
Table 91. Okamoto Industries Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Okamoto Industries Product
Table 93. Okamoto Industries Recent Development
Table 94. Reckitt Benckiser Corporation Information
Table 95. Reckitt Benckiser Description and Major Businesses
Table 96. Reckitt Benckiser Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Reckitt Benckiser Product
Table 98. Reckitt Benckiser Recent Development
Table 99. Lupin Pharmaceuticals Corporation Information
Table 100. Lupin Pharmaceuticals Description and Major Businesses
Table 101. Lupin Pharmaceuticals Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Lupin Pharmaceuticals Product
Table 103. Lupin Pharmaceuticals Recent Development
Table 104. Foundation Consumer Healthcare Corporation Information
Table 105. Foundation Consumer Healthcare Description and Major Businesses
Table 106. Foundation Consumer Healthcare Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Foundation Consumer Healthcare Product
Table 108. Foundation Consumer Healthcare Recent Development
Table 109. Teva Pharmaceuticals Corporation Information
Table 110. Teva Pharmaceuticals Description and Major Businesses
Table 111. Teva Pharmaceuticals Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Teva Pharmaceuticals Product
Table 113. Teva Pharmaceuticals Recent Development
Table 114. Ansell Corporation Information
Table 115. Ansell Description and Major Businesses
Table 116. Ansell Female Contraceptive Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Ansell Product
Table 118. Ansell Recent Development
Table 119. Ferring Pharmaceuticals Corporation Information
Table 120. Ferring Pharmaceuticals Description and Major Businesses
Table 121. Ferring Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Ferring Pharmaceuticals Product
Table 123. Ferring Pharmaceuticals Recent Development
Table 124. Fuji Latex Corporation Information
Table 125. Fuji Latex Description and Major Businesses
Table 126. Fuji Latex Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Fuji Latex Product
Table 128. Fuji Latex Recent Development
Table 129. Janssen Pharmaceuticals Corporation Information
Table 130. Janssen Pharmaceuticals Description and Major Businesses
Table 131. Janssen Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Janssen Pharmaceuticals Product
Table 133. Janssen Pharmaceuticals Recent Development
Table 134. Global Female Contraceptive Sales Forecast by Regions (2021-2026) (K Units)
Table 135. Global Female Contraceptive Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Female Contraceptive Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Female Contraceptive Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Female Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 139. North America: Female Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Female Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 141. Europe: Female Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Female Contraceptive Sales Forecast by Region (2021-2026) (K Units)
Table 143. Asia Pacific: Female Contraceptive Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Female Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 145. Latin America: Female Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Female Contraceptive Sales Forecast by Country (2021-2026) (K Units)
Table 147. Middle East and Africa: Female Contraceptive Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Female Contraceptive Players
Table 152. Female Contraceptive Customers List
Table 153. Female Contraceptive Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Female Contraceptive Product Picture
Figure 2. Global Female Contraceptive Sales Market Share by Type in 2020 & 2026
Figure 3. Female Contraceptive Devices Product Picture
Figure 4. Female Contraceptive Drugs Product Picture
Figure 5. Global Female Contraceptive Sales Market Share by Application in 2020 & 2026
Figure 6. Online Stores
Figure 7. Retail Outlets
Figure 8. Female Contraceptive Report Years Considered
Figure 9. Global Female Contraceptive Market Size 2015-2026 (US$ Million)
Figure 10. Global Female Contraceptive Sales 2015-2026 (K Units)
Figure 11. Global Female Contraceptive Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Female Contraceptive Sales Market Share by Region (2015-2020)
Figure 13. Global Female Contraceptive Sales Market Share by Region in 2019
Figure 14. Global Female Contraceptive Revenue Market Share by Region (2015-2020)
Figure 15. Global Female Contraceptive Revenue Market Share by Region in 2019
Figure 16. Global Female Contraceptive Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Female Contraceptive Revenue in 2019
Figure 18. Female Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Female Contraceptive Sales Market Share by Type (2015-2020)
Figure 20. Global Female Contraceptive Sales Market Share by Type in 2019
Figure 21. Global Female Contraceptive Revenue Market Share by Type (2015-2020)
Figure 22. Global Female Contraceptive Revenue Market Share by Type in 2019
Figure 23. Global Female Contraceptive Market Share by Price Range (2015-2020)
Figure 24. Global Female Contraceptive Sales Market Share by Application (2015-2020)
Figure 25. Global Female Contraceptive Sales Market Share by Application in 2019
Figure 26. Global Female Contraceptive Revenue Market Share by Application (2015-2020)
Figure 27. Global Female Contraceptive Revenue Market Share by Application in 2019
Figure 28. North America Female Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Female Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Female Contraceptive Sales Market Share by Country in 2019
Figure 31. North America Female Contraceptive Revenue Market Share by Country in 2019
Figure 32. U.S. Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Female Contraceptive Market Share by Type in 2019
Figure 37. North America Female Contraceptive Market Share by Application in 2019
Figure 38. Europe Female Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Female Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Female Contraceptive Sales Market Share by Country in 2019
Figure 41. Europe Female Contraceptive Revenue Market Share by Country in 2019
Figure 42. Germany Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Female Contraceptive Market Share by Type in 2019
Figure 53. Europe Female Contraceptive Market Share by Application in 2019
Figure 54. Asia Pacific Female Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Female Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Female Contraceptive Sales Market Share by Region in 2019
Figure 57. Asia Pacific Female Contraceptive Revenue Market Share by Region in 2019
Figure 58. China Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Female Contraceptive Market Share by Type in 2019
Figure 81. Asia Pacific Female Contraceptive Market Share by Application in 2019
Figure 82. Latin America Female Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Female Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Female Contraceptive Sales Market Share by Country in 2019
Figure 85. Latin America Female Contraceptive Revenue Market Share by Country in 2019
Figure 86. Mexico Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Female Contraceptive Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Female Contraceptive Market Share by Type in 2019
Figure 93. Latin America Female Contraceptive Market Share by Application in 2019
Figure 94. Middle East and Africa Female Contraceptive Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Female Contraceptive Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Female Contraceptive Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Female Contraceptive Revenue Market Share by Country in 2019
Figure 98. Turkey Female Contraceptive Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Fe
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs